Immunome (IMNM)
(Delayed Data from NSDQ)
$13.82 USD
+0.09 (0.66%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $13.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/3/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | -92.86% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.91 |
Next Year | -2.36 |
EPS (TTM) | -1.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.00M | 4.00M | 16.00M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 4.00M | 4.00M | 16.00M | NA |
Low Estimate | 4.00M | 4.00M | 16.00M | NA |
Year ago Sales | 2.36M | 4.26M | 14.02M | 16.00M |
Year over Year Growth Est. | 69.49% | -6.10% | 14.14% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.36 | -1.91 | -2.36 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -1.63 | -0.18 | -2.19 | -2.53 |
High Estimate | -0.25 | -0.18 | -1.25 | -1.45 |
Low Estimate | -1.63 | -0.53 | -2.28 | -3.11 |
Year ago EPS | -0.35 | -0.46 | -1.31 | -1.91 |
Year over Year Growth Est. | -128.57% | 21.74% | -45.80% | -23.91% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 3 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.36 | -1.91 | -2.36 |
7 Days Ago | -0.80 | -0.36 | -1.91 | -2.36 |
30 Days Ago | -0.98 | -0.20 | -1.46 | -1.82 |
60 Days Ago | -1.23 | -0.22 | -1.63 | -1.74 |
90 Days Ago | NA | NA | -1.11 | -1.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.36 | -1.91 | -2.36 |
Zacks Consensus Estimate | -0.80 | -0.36 | -1.91 | -2.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.36 | -0.46 | -0.35 | NA |
Estimate | -0.28 | NA | NA | NA | NA |
Difference | -0.26 | NA | NA | NA | -0.26 |
Surprise | -92.86% | NA | NA | NA | -92.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more